$KSS

Is Kohl’s Corporation (KSS) A Good Stock To Buy Now?

The article summarizes a bullish thesis on Kohl’s (KSS). Shares were $17.53 (June 23). Citi upgraded KSS from Neutral to Buy and raised its price target to $22. It cites Yahoo Finance P/E of 7.39 trailing and 12.14 forward, and estimates ~$3.2B free cash flow over five years, with 2026 guidance of $500–600M and net debt ~ $2.1B.

Original reporting
Published Jul 1, 2026, 6:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 10:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Kohl’s Corporation (KSS) A Good Stock To Buy Now? — source image
Decision brief

The 30-second read

$KSSBullishLow
01

Why it matters

For traders, the only fresh decision-relevant input is the analyst rating/price-target change; the rest is thesis framing and comparisons to market valuation ranges.

02

Market read

An analyst upgrade with a higher target can move sentiment and positioning, but the article does not introduce new company fundamentals beyond the cited estimates.

03

What to watch

Lease commitments, execution risk in deleveraging/repurchase timing, and sensitivity of FCF to revenue declines are not validated by new company data in this article.

Relevance 4/10Novelty 4/10Timing: pre-market/early session framing after the Citi upgrade and PT change

Background

The piece summarizes a bullish retail turnaround thesis for Kohl’s, anchored on a Citi upgrade and valuation/cash-flow arguments.

Company-level read

Ticker impact

$KSSBullishMedium confidence
Context

Citi upgraded Kohl’s from Neutral to Buy and raised its price target to $22, citing underappreciated free-cash-flow generation.

Expected impact

Near-term upside bias versus the prior rating, but follow-through depends on whether investors treat the cash-flow assumptions as credible.

Evidence & confidence

The text provides a specific, time-relevant sell-side action (upgrade + new PT) and quantifies the bull case (FCF estimates, leverage, valuation), but it is still a promotional thesis rather than a new company disclosure.

Market effects

Supports a broader retail/turnaround narrative that cash-flow yield and balance-sheet repair can drive valuation re-ratings.

No specific regional linkage beyond US retail equities.

Limited; the thesis is company-specific and US-focused.

Counterpoint

The bull case leans heavily on conservative FCF assumptions and tariff-related benefits; if sales pressure persists or margins/working capital disappoint, the valuation support could weaken.

Key entities

  • Kohl’s Corporation

    US omnichannel retailer; subject of the article’s buy thesis and Citi upgrade/PT raise.

  • Citi Research (Paul Lejuez)

    Upgraded KSS from Neutral to Buy and raised the price target to $22 per the article.

Related articles

$KSSMedAI 8/10

Down 45% This Year: 1 High-Yield Turnaround Machine Under $15 to Buy Hand Over Fist

Kohl’s (KSS) shares closed at $13.06 on May 22, 2026, down 35.35% year to date, and the stock trades at a trailing P/E of 5 and price-to-book of 0.352, according to the article. It cites FY2025 free cash flow of $1.008 billion and a Q4 FY2026 adjusted EPS beat ($1.07 vs. $0.8512) on revenue of $5.17 billion. The piece notes a dividend cut in 2025 and weaker comparable sales (-2.8%).

$DELLMedAI 8/10

Microsoft initiated, Dell upgraded: Wall Street's top analyst calls

Morgan Stanley upgraded Dell to Equal Weight from Underweight and set a $448 target (from $170), citing Dell’s Q1 results and a Taiwan visit as signs it’s managing the semiconductor supply shortage better than peers. Other moves: Guggenheim raised Zscaler to Buy ($214); Citi to Buy Kohl’s ($22); Wells Fargo to Overweight Tandem Diabetes ($27); Truist to Outperform Federal Realty ($130). Truist cut Accenture to Hold ($210); Stephens cut Campbell’s to Equal Weight ($21). Texas Capital cut Caesars

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.

$KSSMedAI 9/10

There's a big buying opportunity in this struggling retailer, Citi says

Citi upgraded Kohl’s (KSS) to buy from neutral and raised its price target to $22 from $14, implying 53% upside from Friday’s close, according to a note by analyst Paul Lejuez. Citi cited improving free cash flow, including $1B in 2024, and projects near-market-cap free cash flow in 2026-27. The article notes Kohl’s has faced declining sales and that its shares rose after a first-quarter earnings report.

$KSSMedAI 9/10

Kohl's Q1 Earnings Call Highlights

Kohl’s executives said Q1 strength in women’s and juniors apparel, led by the SO brand, drove a 10% increase in juniors. Kohl’s Card comparable sales were flat after a mid-single-digit decline in Q4, a 600-basis-point improvement, CFO Jill Timm said. Digital sales rose 4% while stores fell in the low single digits. Net loss was $14M. Kohl’s reaffirmed FY2026 guidance: comps down 2% to flat, operating margin 2.8%–3.4%, EPS $1.00–$1.60.